Cargando…
Relationship between vascular endothelial growth factor expression and thyroid stimulating hormone level in benign and malignant thyroid lesions
BACKGROUND: Vascular endothelial growth factor (VEGF) stimulates angiogenesis, increases vascular permeability and seems to correlate to aggressiveness of tumors. Thyroid cancer has been found to have higher levels of VEGF expression. Thyroid stimulating hormone (TSH) is the most important thyroid h...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9480793/ https://www.ncbi.nlm.nih.gov/pubmed/36119205 http://dx.doi.org/10.4103/jfmpc.jfmpc_1126_21 |
_version_ | 1784791119764127744 |
---|---|
author | Bariya, Deepak Mishra, Shashi Prakash Akshay, BR Kumari, Sweety Akanksha, Khanna, Rahul Meena, Ram Niwas |
author_facet | Bariya, Deepak Mishra, Shashi Prakash Akshay, BR Kumari, Sweety Akanksha, Khanna, Rahul Meena, Ram Niwas |
author_sort | Bariya, Deepak |
collection | PubMed |
description | BACKGROUND: Vascular endothelial growth factor (VEGF) stimulates angiogenesis, increases vascular permeability and seems to correlate to aggressiveness of tumors. Thyroid cancer has been found to have higher levels of VEGF expression. Thyroid stimulating hormone (TSH) is the most important thyroid hormone, yet few researches have been done on its relationship with VEGF. AIM: To study the clinical and demographic profile of thyroid lesions (benign and malignant) and to explored the relationship between VEGF expression (using immunochemistry) and serum TSH level. METHODS: This prospective, observational study includes 61 patients of thyroid lesions who underwent partial, hemi, subtotal or total thyroidectomy as the primary treatment from June 2014 and July 2016. Tissue specimens of thyroid lesions for immunohistochemistry study of VEGF expression were done. Serum TSH was done using Chemiluminiscence technique and correlated to VEGF expression. RESULTS: The mean age of patient was 36.26 ± 11.53 years (range 20-50 years) with female preponderance. Swelling was the most common presenting symptom. Of 61 patients, 37 (60.65%) patients were benign and 24 (39.35%) were malignant thyroid lesions. The mean TSH level in benign group was 1.92 ± 0.94 mIU/liter and malignant group was 2.73 ± 1.74 mIU/liter which was statistically significant (P = 0.023). VEGF expression was strongly positive (3+) in 26 (42.62%) patients and negative/equivocal (1+ & 2+) in 35 (57.38%) patients. In benign group, 10 (27.0%) patients were strongly positive for VEGF whereas in malignant group, 16 (66.7%) patients were strongly positive for VEGF showed significant association (P = 0.002). On comparing TSH level of benign, malignant and total patients separately with VEGF expression, significant association were also observed (P < 0.001, P = 0.004 and P < 0.001, respectively). CONCLUSION: VEGF was strongly expressed in malignant thyroid lesions which are having high serum concentration of serum TSH level. Serum TSH levels reveal a significant correlation with VEGF expression. |
format | Online Article Text |
id | pubmed-9480793 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-94807932022-09-17 Relationship between vascular endothelial growth factor expression and thyroid stimulating hormone level in benign and malignant thyroid lesions Bariya, Deepak Mishra, Shashi Prakash Akshay, BR Kumari, Sweety Akanksha, Khanna, Rahul Meena, Ram Niwas J Family Med Prim Care Original Article BACKGROUND: Vascular endothelial growth factor (VEGF) stimulates angiogenesis, increases vascular permeability and seems to correlate to aggressiveness of tumors. Thyroid cancer has been found to have higher levels of VEGF expression. Thyroid stimulating hormone (TSH) is the most important thyroid hormone, yet few researches have been done on its relationship with VEGF. AIM: To study the clinical and demographic profile of thyroid lesions (benign and malignant) and to explored the relationship between VEGF expression (using immunochemistry) and serum TSH level. METHODS: This prospective, observational study includes 61 patients of thyroid lesions who underwent partial, hemi, subtotal or total thyroidectomy as the primary treatment from June 2014 and July 2016. Tissue specimens of thyroid lesions for immunohistochemistry study of VEGF expression were done. Serum TSH was done using Chemiluminiscence technique and correlated to VEGF expression. RESULTS: The mean age of patient was 36.26 ± 11.53 years (range 20-50 years) with female preponderance. Swelling was the most common presenting symptom. Of 61 patients, 37 (60.65%) patients were benign and 24 (39.35%) were malignant thyroid lesions. The mean TSH level in benign group was 1.92 ± 0.94 mIU/liter and malignant group was 2.73 ± 1.74 mIU/liter which was statistically significant (P = 0.023). VEGF expression was strongly positive (3+) in 26 (42.62%) patients and negative/equivocal (1+ & 2+) in 35 (57.38%) patients. In benign group, 10 (27.0%) patients were strongly positive for VEGF whereas in malignant group, 16 (66.7%) patients were strongly positive for VEGF showed significant association (P = 0.002). On comparing TSH level of benign, malignant and total patients separately with VEGF expression, significant association were also observed (P < 0.001, P = 0.004 and P < 0.001, respectively). CONCLUSION: VEGF was strongly expressed in malignant thyroid lesions which are having high serum concentration of serum TSH level. Serum TSH levels reveal a significant correlation with VEGF expression. Wolters Kluwer - Medknow 2022-06 2022-06-30 /pmc/articles/PMC9480793/ /pubmed/36119205 http://dx.doi.org/10.4103/jfmpc.jfmpc_1126_21 Text en Copyright: © 2022 Journal of Family Medicine and Primary Care https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Bariya, Deepak Mishra, Shashi Prakash Akshay, BR Kumari, Sweety Akanksha, Khanna, Rahul Meena, Ram Niwas Relationship between vascular endothelial growth factor expression and thyroid stimulating hormone level in benign and malignant thyroid lesions |
title | Relationship between vascular endothelial growth factor expression and thyroid stimulating hormone level in benign and malignant thyroid lesions |
title_full | Relationship between vascular endothelial growth factor expression and thyroid stimulating hormone level in benign and malignant thyroid lesions |
title_fullStr | Relationship between vascular endothelial growth factor expression and thyroid stimulating hormone level in benign and malignant thyroid lesions |
title_full_unstemmed | Relationship between vascular endothelial growth factor expression and thyroid stimulating hormone level in benign and malignant thyroid lesions |
title_short | Relationship between vascular endothelial growth factor expression and thyroid stimulating hormone level in benign and malignant thyroid lesions |
title_sort | relationship between vascular endothelial growth factor expression and thyroid stimulating hormone level in benign and malignant thyroid lesions |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9480793/ https://www.ncbi.nlm.nih.gov/pubmed/36119205 http://dx.doi.org/10.4103/jfmpc.jfmpc_1126_21 |
work_keys_str_mv | AT bariyadeepak relationshipbetweenvascularendothelialgrowthfactorexpressionandthyroidstimulatinghormonelevelinbenignandmalignantthyroidlesions AT mishrashashiprakash relationshipbetweenvascularendothelialgrowthfactorexpressionandthyroidstimulatinghormonelevelinbenignandmalignantthyroidlesions AT akshaybr relationshipbetweenvascularendothelialgrowthfactorexpressionandthyroidstimulatinghormonelevelinbenignandmalignantthyroidlesions AT kumarisweety relationshipbetweenvascularendothelialgrowthfactorexpressionandthyroidstimulatinghormonelevelinbenignandmalignantthyroidlesions AT akanksha relationshipbetweenvascularendothelialgrowthfactorexpressionandthyroidstimulatinghormonelevelinbenignandmalignantthyroidlesions AT khannarahul relationshipbetweenvascularendothelialgrowthfactorexpressionandthyroidstimulatinghormonelevelinbenignandmalignantthyroidlesions AT meenaramniwas relationshipbetweenvascularendothelialgrowthfactorexpressionandthyroidstimulatinghormonelevelinbenignandmalignantthyroidlesions |